Evidence map›Paper›PMID 40500406›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Medial nucleus accumbens dopamine receptors modulate motivation for wheel running in male mice.

Naoya Nishitani, Taisuke Kokume, Harumi Taniguchi, Katsuyuki Kaneda

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Adenosine APsychopharmacology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Naoya NishitaniLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, 920-1192, Japan.
Taisuke KokumeLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, 920-1192, Japan.
Harumi TaniguchiLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, 920-1192, Japan.
Katsuyuki KanedaLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, 920-1192, Japan. k-kaneda@p.kanazawa-u.ac.jp.ORCID http://orcid.org/0000-0001-7046-9275

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) JP18K06520,JP23H02793,JP21K18548, JP23K18419MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15290
6 · The paper itself

Abstract

Abnormal motivation for natural rewards is a hallmark of various psychiatric disorders, including behavioral addiction. The mesolimbic dopamine pathway has been identified as a critical modulator of motivated behavior primarily based on studies using food-reinforced operant tasks. However, the focus on food rewards in previous studies limits the generalizability of these findings to other natural rewards implicated in behavioral addiction. In this study, we investigated the reinforcing and high motivational properties of wheel running in rodents by developing a wheel running-reinforced operant conditioning procedure. This procedure allowed for the independent quantification of appetitive and consummatory behaviors as operant responses and running duration, respectively, facilitating an in-depth exploration of the role of dopamine signaling in the medial nucleus accumbens (mNAc) in wheel running motivation. The results indicated that the systemic inhibition of dopamine D

Indexed as

MotivationMotor ActivityNucleus AccumbensReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D2RunningAnimalsBenzazepinesConditioning, OperantDopamine AntagonistsMaleMiceMice, Inbred C57BLBenzazepinesDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D2

Identifiers

PMID40500406
PMCPMC12603203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.